These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8316922)

  • 1. Normal left ventricular function does not protect against propafenone-induced incessant ventricular tachycardia.
    Millar RN; Lawrenson JB; Milne DA
    S Afr Med J; 1993 Apr; 83(4):256-9. PubMed ID: 8316922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy and safety of intravenous propafenone in the acute treatment of spontaneous sustained ventricular tachycardia].
    Mestre JL; Moro C; Madrid AH; Novo L; Marín-Huerta E
    Rev Esp Cardiol; 1994 Jul; 47(7):461-7. PubMed ID: 8090973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained ventricular tachycardia occurring during propafenone therapy.
    De Jaegere P; Huyghens L; Dewilde P
    Acta Cardiol; 1987; 42(3):207-12. PubMed ID: 3499736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone: a novel type Ic antiarrhythmic agent.
    Parker RB; McCollam PL; Bauman JL
    DICP; 1989 Mar; 23(3):196-202. PubMed ID: 2655298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
    Vergara G; Disertori M; Inama G; Guarnerio M; Bettini R; Durante G; Stirpe E; Furlanello F
    G Ital Cardiol; 1984 Dec; 14(12):972-81. PubMed ID: 6532893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone.
    Stavens CS; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1985 Jul; 110(1 Pt 1):24-9. PubMed ID: 4013986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ventricular tachycardia during propafenone treatment in a child with junctional automatic tachycardia: effectiveness of intravenous molar sodium lactate.
    Scanu P; Grollier G; Guilleman D; Iselin M; Bustany P; Hurpe JM; Potier JC
    Pacing Clin Electrophysiol; 1991 May; 14(5 Pt 1):783-6. PubMed ID: 1712954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts].
    Drago F; Vignati G; Agostino DA; Mauri L; Calzolari A; Figini A; Ragonese P
    G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of young children with permanent junctional reciprocating tachycardia.
    van Stuijvenberg M; Beaufort-Krol GC; Haaksma J; Bink-Boelkens MT
    Cardiol Young; 2003 Oct; 13(5):408-12. PubMed ID: 14694933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of recurrent ventricular tachycardias using oral propafenone].
    Cointe R; Lévy S; Metge M; Vrancea F; Labrunie P; Valeix B; Gérard R
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():59-62. PubMed ID: 3938260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
    Lucet V; Do Ngoc D; Fidelle J; Sidi D; Batisse A; Loth P; Vrancea F; Villain E; Coumel P
    Arch Mal Coeur Vaiss; 1987 Aug; 80(9):1385-93. PubMed ID: 3122689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias.
    Kowey PR; Stohler JL; Friehling TD; Marinchak RA
    Can J Cardiol; 1991 May; 7(4):175-80. PubMed ID: 2070286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained monomorphic ventricular tachycardia after adenosine infusion.
    Huemer M; Boldt LH; Rolf S; Blaschke D; Parwani A; Haverkamp W
    Int J Cardiol; 2009 Jan; 131(3):e97-100. PubMed ID: 18006091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function].
    Saitta A; Bonaiuto M; Mileto A; Oriti S; Cinquegrani M; Giordano G; Fodale P; Saitta M; Squadrito F
    Clin Ter; 1993 Apr; 142(4):351-60. PubMed ID: 8330479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Life-threatening ventricular arrhythmia during simultaneous administration of propafenone and sotatol].
    Gilewski W; Bednarska D; Sinkiewicz W
    Kardiol Pol; 2009 Aug; 67(8):916-20; discussion 921. PubMed ID: 19784892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.